Skip Navigation

繁體中文 EN ESPAÑOL

Get the details on health reform for employers, and check small group eligibility for tax credits.

Learn More
Review Your Provider Profile
Learn More

Locate a doctor, hospital or other health care services near you.

Search Now

At EmblemHealth we’re dedicated to helping you stay healthy, get well and live better.

Learn More

Learn about EmblemHealth’s pharmacy benefits.

Learn More
Learn More
Getting Ready for
ICD–10 Together

ICD-10 and Your Office FAQ

Vendor Fact Sheet

Learn more

The latest news about our benefit plans, vendor programs and administrative guidelines. Plus the latest health news from the New York City and New York State Departments of Health and the FDA.

Health Alerts See All

Date Issued
Title
4/1/2015
0.9 Percent Sodium Chloride Injection, USP, 250 mL VisIV Container by Hospira: Recall - Particulate Matter
4/1/2015
FDA Drug Safety Communication: FDA strengthens warnings and changes prescribing instructions to decrease the risk of serious allergic reactions with anemia drug Feraheme (ferumoxytol)
4/1/2015
FDA Drug Safety Communication: FDA warns of serious slowing of the heart rate when antiarrhythmic drug amiodarone is used with hepatitis C treatments containing sofosbuvir Harvoni or Sovaldi in combination with another Direct Acting Antiviral drug
4/1/2015
FDA Drug Safety Communication: FDA review of study sheds light on two deaths associated with the injectable schizophrenia drug Zyprexa Relprevv (olanzapine pamoate)
4/1/2015
FDA warns consumers about the potential health risks of over-the-counter asthma products labeled as homeopathic
4/1/2015
Hospira Issues a Voluntary Nationwide Recall of One Lot of Lactated Ringer's Irrigation Due to Mold Contamination
4/1/2015
Chantix (varenicline): Drug Safety Communication - FDA Updates Label to Include Potential Alcohol Interaction
4/1/2015
Hospira Issues a Voluntary Nationwide Recall of One Lot of Magnesium Sulfate in 5% Dextrose Injection Due to Incorrect Barcode Labeling
3/5/2015
Atracurium Besylate Injection by Sagent Pharmaceuticals: Recall - Potential Impact on Product Sterility
3/5/2015
Testosterone Products: - FDA Cautions About Using Testosterone Products for Low Testosterone Due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack And Stroke

You are now leaving the Medicare section of the EmblemHealth website.

Click to Continue ×

Your member ID # is on the front of your ID card.

In most cases, if you are the policy holder, you can also use your Social Security Number to register.